Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new data at the 2025 San Antonio Breast Cancer Symposium ...
They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback